Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7T17

Zika Virus asymmetric unit bound with IgM antibody DH1017 Fab fragment

7T17 の概要
エントリーDOI10.2210/pdb7t17/pdb
EMDBエントリー25606
分子名称DH1017.IgM FabC constant domain, DH1017.IgM LambdaC constant domain, DH1017.IgM IgH, ... (5 entities in total)
機能のキーワードzika virus particle, igm, fab fragment, neutralization, virus
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数9
化学式量合計199678.72
構造登録者
Miller, A.S.,Kuhn, R.J. (登録日: 2021-12-01, 公開日: 2022-11-23, 最終更新日: 2024-06-05)
主引用文献Singh, T.,Hwang, K.K.,Miller, A.S.,Jones, R.L.,Lopez, C.A.,Dulson, S.J.,Giuberti, C.,Gladden, M.A.,Miller, I.,Webster, H.S.,Eudailey, J.A.,Luo, K.,Von Holle, T.,Edwards, R.J.,Valencia, S.,Burgomaster, K.E.,Zhang, S.,Mangold, J.F.,Tu, J.J.,Dennis, M.,Alam, S.M.,Premkumar, L.,Dietze, R.,Pierson, T.C.,Ooi, E.E.,Lazear, H.M.,Kuhn, R.J.,Permar, S.R.,Bonsignori, M.
A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization.
Cell, 185:4826-4840.e17, 2022
Cited by
PubMed Abstract: Congenital Zika virus (ZIKV) infection results in neurodevelopmental deficits in up to 14% of infants born to ZIKV-infected mothers. Neutralizing antibodies are a critical component of protective immunity. Here, we demonstrate that plasma IgM contributes to ZIKV immunity in pregnancy, mediating neutralization up to 3 months post-symptoms. From a ZIKV-infected pregnant woman, we isolated a pentameric ZIKV-specific IgM (DH1017.IgM) that exhibited ultrapotent ZIKV neutralization dependent on the IgM isotype. DH1017.IgM targets an envelope dimer epitope within domain II. The epitope arrangement on the virion is compatible with concurrent engagement of all ten antigen-binding sites of DH1017.IgM, a solution not available to IgG. DH1017.IgM protected mice against viremia upon lethal ZIKV challenge more efficiently than when expressed as an IgG. Our findings identify a role for antibodies of the IgM isotype in protection against ZIKV and posit DH1017.IgM as a safe and effective candidate immunotherapeutic, particularly during pregnancy.
PubMed: 36402135
DOI: 10.1016/j.cell.2022.10.023
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (5.26 Å)
構造検証レポート
Validation report summary of 7t17
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon